Abstract:Presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein (APP) have been recognized as the major pathogenic genes of FAD. However, the frequency and predicted risk factors of these 3 pathogenic genes of FAD in China is still unclear. 160 FAD families have been recruited from Chinese Familial Alzheimer's Disease Network (CFAN, https://www.chinacfan.org/) from Jan 2013 to Dec 2014. According to age at onset (AAO) of the proband, 93 FAD families (58.1%) were classified as early-onset (<65 years old) FAD (EOFAD) and 67 (41.9%) families were late-onset (≥65 years old) AD (LOFAD). Clinical features, neuropsychological assessments, imaging and blood and CSF samples were collected from these pedigrees following standard protocols. Mutational screening of PSEN1, PSEN2, APP genes and genotype analysis of ApoE were performed in all of the 160 FAD families. Twenty-two pedigrees (23.7% of EOFAD) were identified with mutations in PSEN1, PSEN2 or APP. Specifically, 13 (59.1%) were PSEN1 mutations (4 novel and 9 previously reported), 8 (36.4%) were APP mutations (1 novel and 7 reported), and one (4.5%) was PSEN2 novel mutations (Table 1). Compared to FAD families without known mutations, the FAD families with mutations tended to present significantly lower mean age at onset (AAO), affect more family members and more generations, and carry less ApoEε4 allele (Table 2). When the equation was applied as followed: risk score= -1×AAO+3×the number of affected individuals+10×ApoE ε4 positive, the FAD with mutations were predicted very well (area under curve 0.89) with the high sensitivity (68%) and specificity (98%) (Figure 1). For phenotype of FAD families with mutations, there were no group difference in PSEN1 and APP mutations pedigrees in terms of mean AAO (54.4 vs 50.0 years, p=0.383), the number of affected family members (6.5 vs 5.8, p=0.724) and affected generations, or ApoE ε4 status (Table 3). Six novel mutations in PSEN1, PSEN2 or APP were identified in Chinese Han FAD pedigrees. FAD with mutations was significantly predicted by the number of affected individuals, AAO and ApoEε4. No significant difference between APP and PSEN1 mutations was found in China in terms of phenotype.

Mutational analysis in early-onset familial Alzheimer's disease in Mainland China.

Presenilin 1 and APP Gene Mutations in Early-Onset AD Families from a Southeast Region of China.

Clinical and genetic characteristics in a central-southern Chinese cohort of early-onset Alzheimer's disease

P3‐120: MOLECULAR GENETIC ANALYSIS OF APP, PSEN1, AND PSEN2 GENES IN CHINESE PATIENTS WITH ALZHEIMER'S DISEASE

Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease

Clinical and Genetic Analysis of Early-Onset Alzheimer's Disease in Two Chinese Han Families with Presenilin-1 Mutations

P2‐017: Mutation Frequency of Pathogenic Genes in Familial Alzheimer's Disease in China

An APP Mutation Family Exhibiting White Matter Hyperintensities and Cortical Calcification in East China

Mutation Screening in Chinese Patients with Familial Alzheimer's Disease by Whole-Exome Sequencing.

PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer's disease.

Genetic Screening of Patients with Sporadic Alzheimer's Disease and Frontotemporal Lobar Degeneration in the Chinese Population

Early-onset familial Alzheimer's disease in a family with mutation of presenilin 2 gene.

Identification Of C9orf72 Repeat Expansions In Patients With Amyotrophic Lateral Sclerosis And Frontotemporal Dementia In Mainland China

Two Novel Mutations and a De Novo Mutation in PSEN1 in Early-onset Alzheimer’s Disease

A clinical and genetic study on early-onset Alzheimer's disease associated with presenilin-1 in three Chinese families

Identification of a Novel Mutation in the Presenilin 1 Gene in a Chinese Alzheimer’s Disease Family

A novel presenilin 1 mutation (Ser169del) in a Chinese family with early-onset Alzheimer's disease.

Mutation and association analyses of dementia-causal genes in Han Chinese patients with early-onset and familial Alzheimer's disease.

Analyses Mutations in GSN, CST3, TTR, and ITM2B Genes in Chinese Patients with Alzheimer’s Disease

Clinical And Neuroimaging Characterization Of Chinese Dementia Patients With Psen1 And Psen2 Mutations

Genetic Profiles of Familial Late-Onset Alzheimer's Disease in China: the Shanghai FLOAD Study